187 related articles for article (PubMed ID: 27082818)
1. Anti-inflammatory effects of novel AP-1 and NF-κB inhibitors in dextran-sulfate-sodium-induced colitis in rats.
El-Salhy M; Umezawa K
Int J Mol Med; 2016 Jun; 37(6):1457-64. PubMed ID: 27082818
[TBL] [Abstract][Full Text] [Related]
2. Treatment with novel AP-1 and NF-κB inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis.
El-Salhy M; Umezawa K
Int J Mol Med; 2016 Mar; 37(3):556-64. PubMed ID: 26846574
[TBL] [Abstract][Full Text] [Related]
3. Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis.
El-Salhy M; Umezawa K
Mol Med Rep; 2016 Aug; 14(2):1515-22. PubMed ID: 27357734
[TBL] [Abstract][Full Text] [Related]
4. Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
Ichikawa N; Yamashita K; Funakoshi T; Ichihara S; Fukai M; Ogura M; Kobayashi N; Zaitsu M; Yoshida T; Shibasaki S; Koshizuka Y; Tsunetoshi Y; Sato M; Einama T; Ozaki M; Umezawa K; Suzuki T; Todo S
Inflamm Res; 2016 Mar; 65(3):245-60. PubMed ID: 26683259
[TBL] [Abstract][Full Text] [Related]
5. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of severe TNBS induced colitis by novel AP-1 and NF- κ B inhibitors in rats.
El-Salhy M; Umezawa K; Gilja OH; Hatlebakk JG; Gundersen D; Hausken T
ScientificWorldJournal; 2014; 2014():813804. PubMed ID: 24616647
[TBL] [Abstract][Full Text] [Related]
7. Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis.
El-Salhy M; Mazzawi T; Umezawa K; Gilja OH
Int J Mol Med; 2016 Dec; 38(6):1743-1751. PubMed ID: 27779708
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S
Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193
[TBL] [Abstract][Full Text] [Related]
9. Abnormal differentiation of stem cells into enteroendocrine cells in rats with DSS-induced colitis.
El-Salhy M; Umezawa K; Hatlebakk JG; Gilja OH
Mol Med Rep; 2017 Apr; 15(4):2106-2112. PubMed ID: 28259987
[TBL] [Abstract][Full Text] [Related]
10. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-κB inhibitor DTCM-glutarimide.
Koide N; Kaneda A; Yokochi T; Umezawa K
Int Immunopharmacol; 2015 Mar; 25(1):162-8. PubMed ID: 25617668
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MMP-2-Mediated Mast Cell Invasion by NF-κB Inhibitor DHMEQ in Mast Cells.
Noma N; Asagiri M; Takeiri M; Ohmae S; Takemoto K; Iwaisako K; Minato N; Maeda-Yamamoto M; Simizu S; Umezawa K
Int Arch Allergy Immunol; 2015; 166(2):84-90. PubMed ID: 25791818
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities in endocrine and immune cells are correlated in dextran‑sulfate‑sodium‑induced colitis in rats.
El-Salhy M; Hatlebakk JG; Gilja OH
Mol Med Rep; 2017 Jan; 15(1):12-20. PubMed ID: 27959399
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of inflammatory mediator secretion by (-)-DHMEQ in mouse bone marrow-derived macrophages.
Suzuki E; Sugiyama C; Umezawa K
Biomed Pharmacother; 2009 Jun; 63(5):351-8. PubMed ID: 18635336
[TBL] [Abstract][Full Text] [Related]
15. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes.
Cardile V; Libra M; Caggia S; Frasca G; Umezawa K; Stivala F; Mazzarino MC; Bevelacqua Y; Coco M; Malaponte G
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):679-83. PubMed ID: 20337659
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of macrophage activation and suppression of graft rejection by DTCM-glutarimide, a novel piperidine derived from the antibiotic 9-methylstreptimidone.
Takeiri M; Tachibana M; Kaneda A; Ito A; Ishikawa Y; Nishiyama S; Goto R; Yamashita K; Shibasaki S; Hirokata G; Ozaki M; Todo S; Umezawa K
Inflamm Res; 2011 Sep; 60(9):879-88. PubMed ID: 21625968
[TBL] [Abstract][Full Text] [Related]
17. Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1, 2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats.
Arigesavan K; Sudhandiran G
Biochem Biophys Res Commun; 2015 May; 461(2):314-20. PubMed ID: 25881504
[TBL] [Abstract][Full Text] [Related]
18. Monotropein isolated from the roots of Morinda officinalis ameliorates proinflammatory mediators in RAW 264.7 macrophages and dextran sulfate sodium (DSS)-induced colitis via NF-κB inactivation.
Shin JS; Yun KJ; Chung KS; Seo KH; Park HJ; Cho YW; Baek NI; Jang D; Lee KT
Food Chem Toxicol; 2013 Mar; 53():263-71. PubMed ID: 23261679
[TBL] [Abstract][Full Text] [Related]
19. Tea catechins induce crosstalk between signaling pathways and stabilize mast cells in ulcerative colitis.
Gerges Geagea A; Rizzo M; Eid A; Hajj Hussein I; Zgheib Z; Zeenny MN; Jurjus R; Uzzo ML; Spatola GF; Bonaventura G; Leone A; Massaad-Massade L; Jurjus A
J Biol Regul Homeost Agents; 2017; 31(4):865-877. PubMed ID: 29254289
[TBL] [Abstract][Full Text] [Related]
20. Kefir treatment ameliorates dextran sulfate sodium-induced colitis in rats.
Senol A; Isler M; Sutcu R; Akin M; Cakir E; Ceyhan BM; Kockar MC
World J Gastroenterol; 2015 Dec; 21(46):13020-9. PubMed ID: 26676086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
